Literature DB >> 3277395

Coexisting adenocarcinoma and malignant lymphoma of the stomach: case report and review of the Japanese literature.

Y Kasahara1, M Takemoto, A Morishita, T Kuyama, M Takahashi, K Tanji.   

Abstract

After a diagnosis of advanced carcinoma, a 77-yr-old female underwent gastrectomy. A 6 X 5 cm ulcerative mass in the angle was shown to be differentiated adenocarcinoma in the surrounding wall, and malignant lymphoma in the bottom. Carcinomatous infiltration was limited to the muscularis mucosae. Neither generalized lymphoma nor locoregional lymph node metastasis of either neoplasm was noted. A survey of 35 Japanese patients, including our own case with the two coexistent neoplasms in the stomach, revealed that the male-to-female ratio was 2.3:1, with no significant difference between the mean age of the sexes. The prevalence of adenocarcinoma in its early stage (60% of 35 patients) and of a histologically differentiated type (85% of 27 patients) of adenocarcinoma is quite different from that of usual Japanese gastric carcinoma, and it may suggest that there are some factors influencing the coexistent development of both neoplasms.

Entities:  

Mesh:

Year:  1988        PMID: 3277395

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Synchronous adenocarcinoma and primary malignant lymphoma of the stomach.

Authors:  A B Akosa; D M Clark; L Desa
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.

Authors:  Erhan Hamaloglu; Serdar Topaloglu; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Ileocecal collision tumor composed of adenocarcinoma and primary malignant lymphoma.

Authors:  Takashi Shigeno; Kazuya Fujimori; Fumito Tsuruta; Yuichi Nozawa; Tadanobu Nagaya; Toshitaka Maejima
Journal:  Clin J Gastroenterol       Date:  2011-02-16

4.  Synchronous lymphoma and adenocarcinoma occurring as a collision tumor in the stomach: report of a case.

Authors:  N Nishino; H Konno; S Baba; K Aoki; T Nishimura; T Arai; I Kino
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 5.  Simultaneous gastric adenocarcinoma and MALT-type lymphoma in Helicobacter pylori infection.

Authors:  A von Herbay; H Schreiter; J Rudi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma.

Authors:  A Enno; J L O'Rourke; C R Howlett; A Jack; M F Dixon; A Lee
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

7.  Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma.

Authors:  Koji Inaba; Ryoji Kushima; Naoya Murakami; Yuuki Kuroda; Ken Harada; Mayuka Kitaguchi; Kotaro Yoshio; Shuhei Sekii; Kana Takahashi; Madoka Morota; Hiroshi Mayahara; Yoshinori Ito; Minako Sumi; Takashi Uno; Jun Itami
Journal:  BMC Cancer       Date:  2013-10-26       Impact factor: 4.430

Review 8.  Gastric collision tumors: an insight into their origin and clinical significance.

Authors:  Adamantios Michalinos; Anastasia Constantinidou; Michael Kontos
Journal:  Gastroenterol Res Pract       Date:  2015-02-12       Impact factor: 2.260

9.  Collision tumors in the gastrointestinal tract: a rare case series.

Authors:  Aruna Bhattacharya; Rama Saha; Jayanta Biswas; Jhuma Biswas; Biswajit Ghosh
Journal:  Int Med Case Rep J       Date:  2012-10-25

10.  Collision tumour of the stomach with a cancer to cancer metastasis: a case report.

Authors:  Alexandros Strofilas; Ioannis G Dalianoudis; Emmanuel E Lagoudianakis; Michael Genetzakis; Dimitrios Tsekouras; John Chrysikos; Nikolaos Koronakis; Vaggelogiannis Katergiannakis; Andreas Manouras
Journal:  Cases J       Date:  2008-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.